• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中脑细胞毒性T细胞作为进行性核上性麻痹的一种独特神经病理学特征。

Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy.

作者信息

Couto Blas, Forrest Shelley L, Fearon Conor, Lee Seojin, Knott Samantha, Li Jun, Fox Susan H, Tartaglia Maria Carmela, Lang Anthony E, Kovacs Gabor G

机构信息

Favaloro University Hospital, Institute of Cognitive and Translational Neuroscience (INCyT) Favaloro-INECO-CONICET, Buenos Aires CA1020, Argentina.

Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario M5T 0S8, Canada.

出版信息

Brain. 2025 Aug 1;148(8):2650-2657. doi: 10.1093/brain/awaf135.

DOI:10.1093/brain/awaf135
PMID:40233181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12316005/
Abstract

Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by four-repeat (4R) tau protein deposition. The substantia nigra (SN) and midbrain tegmentum nuclei (MBT) are consistently affected. Lymphocyte infiltrates are scarce in the brains of patients with neurodegenerative diseases, although a few reports have described their presence in the α-synucleinopathy Parkinson's disease (PD). To evaluate the cytotoxic T-cell response, serial sections spanning 120 μm of the SN were immunostained consecutively for phosphorylated tau (p-tau, AT8) or α-synuclein, cytotoxic T-cell marker and microglia marker HLA-DR. Sections were analysed with stereology software in 9 patients with PSP, 10 with PD and 6 healthy controls. We semiquantitatively scored CD8-positive cells in further brain regions. CD8 lymphocyte cell counts and microglial activation in the SN were higher in PSP than PD and controls. Furthermore, T-cell/neuron contact was observed in PSP. In multivariate models, CD8 counts were not predicted by disease duration, younger age at death or the amount of p-tau pathology. The SN and midbrain tegmentum showed more CD8 cells than the cortex. A more prominent nigral cytotoxic T-cell response in PSP than PD supports the suggestion that p-tau neuropathology in PSP might have potential relationships with autoimmune mechanisms.

摘要

进行性核上性麻痹(PSP)是一种以四重复(4R)tau蛋白沉积为特征的神经退行性疾病。黑质(SN)和中脑被盖核(MBT)持续受到影响。神经退行性疾病患者大脑中的淋巴细胞浸润很少,尽管有一些报告描述了其在α-突触核蛋白病帕金森病(PD)中的存在。为了评估细胞毒性T细胞反应,对跨越SN 120μm的连续切片依次进行磷酸化tau(p-tau,AT8)或α-突触核蛋白、细胞毒性T细胞标志物和小胶质细胞标志物HLA-DR的免疫染色。使用体视学软件对9例PSP患者、10例PD患者和6例健康对照的切片进行分析。我们对其他脑区的CD8阳性细胞进行了半定量评分。PSP患者SN中的CD8淋巴细胞计数和小胶质细胞活化高于PD患者和对照组。此外,在PSP中观察到T细胞与神经元的接触。在多变量模型中,CD8计数不能由疾病持续时间、死亡时较年轻的年龄或p-tau病理改变量预测。SN和中脑被盖的CD8细胞比皮质更多。PSP中黑质细胞毒性T细胞反应比PD更明显,这支持了PSP中的p-tau神经病理学可能与自身免疫机制存在潜在关系的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f2/12316005/ee54af784408/awaf135f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f2/12316005/cc0800ef0347/awaf135f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f2/12316005/f30d915912d9/awaf135f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f2/12316005/ee54af784408/awaf135f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f2/12316005/cc0800ef0347/awaf135f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f2/12316005/f30d915912d9/awaf135f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f2/12316005/ee54af784408/awaf135f3.jpg

相似文献

1
Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy.中脑细胞毒性T细胞作为进行性核上性麻痹的一种独特神经病理学特征。
Brain. 2025 Aug 1;148(8):2650-2657. doi: 10.1093/brain/awaf135.
2
MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy.MAPT 基因单倍型相关的进行性核上性麻痹转录组学变化。
Acta Neuropathol Commun. 2024 Aug 17;12(1):135. doi: 10.1186/s40478-024-01839-3.
3
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.α-突触核蛋白种子扩增检测动力学指标在帕金森病中的诊断和预后价值:一项纵向队列研究
Lancet Neurol. 2025 Jul;24(7):580-590. doi: 10.1016/S1474-4422(25)00157-7.
4
Tau PET imaging in progressive supranuclear palsy: a systematic review and meta-analysis.tau PET 成像在进行性核上性麻痹中的应用:系统评价和荟萃分析。
J Neurol. 2023 May;270(5):2451-2467. doi: 10.1007/s00415-022-11556-3. Epub 2023 Jan 12.
5
Astrocyte tau deposition in progressive supranuclear palsy is associated with dysregulation of MAPT transcription.星形胶质细胞 tau 沉积与进行性核上性麻痹中 MAPT 转录的失调有关。
Acta Neuropathol Commun. 2024 Aug 14;12(1):132. doi: 10.1186/s40478-024-01844-6.
6
Associations between neuropsychological profile and regional brain FDG uptake in progressive supranuclear palsy.进行性核上性麻痹患者神经心理学特征与脑区氟代脱氧葡萄糖摄取之间的关联
J Parkinsons Dis. 2025 Jun;15(4):904-912. doi: 10.1177/1877718X251343080. Epub 2025 May 25.
7
DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation.多系统萎缩、帕金森病和进行性核上性麻痹额顶叶白质的 DNA 甲基化模式:交叉比较研究。
Acta Neuropathol. 2024 Jul 12;148(1):4. doi: 10.1007/s00401-024-02764-4.
8
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.组织因子及其在帕金森病中的脑脊液蛋白谱。
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.
9
[An autopsy case of a 76-year-old woman with progressive supranuclear palsy initially presenting with dropped head and clinical features of pure akinesia with gait freezing].[一名76岁女性进行性核上性麻痹的尸检病例,最初表现为低头以及单纯运动不能伴步态冻结的临床特征]
Rinsho Shinkeigaku. 2025 Jun 26;65(6):436-440. doi: 10.5692/clinicalneurol.cn-002088. Epub 2025 May 20.
10
In search of the optimal MRI marker for progressive supranuclear palsy: a large, single-center, retrospective study on the effect of phenotype, diagnostic certainty and disease duration.寻找进行性核上性麻痹的最佳MRI标志物:一项关于表型、诊断确定性和疾病持续时间影响的大型单中心回顾性研究。
J Neurol. 2025 Jul 21;272(8):523. doi: 10.1007/s00415-025-13262-2.

引用本文的文献

1
Neuroinflammation distinguishes HLA haplotypes in progressive supranuclear palsy.神经炎症在进行性核上性麻痹中区分HLA单倍型。
medRxiv. 2025 Jul 21:2025.07.21.25331869. doi: 10.1101/2025.07.21.25331869.

本文引用的文献

1
Investigation of the HLA locus in autopsy-confirmed progressive supranuclear palsy.经尸检确诊的进行性核上性麻痹患者 HLA 位点的研究。
Immunobiology. 2025 May;230(3):152892. doi: 10.1016/j.imbio.2025.152892. Epub 2025 Mar 22.
2
Nigral Neuroinflammation and Dopaminergic Neurons in Parkinson's Disease and Atypical Parkinsonisms.帕金森病和非典型帕金森综合征中的黑质神经炎症与多巴胺能神经元
Ann Neurol. 2025 Jun;97(6):1096-1109. doi: 10.1002/ana.27202. Epub 2025 Feb 7.
3
Current concepts and molecular pathology of neurodegenerative diseases.
神经退行性疾病的当前概念与分子病理学
Pathology. 2025 Mar;57(2):178-190. doi: 10.1016/j.pathol.2024.10.006. Epub 2024 Nov 14.
4
Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy.抗 IgLON5 病的神经病理学谱和脑干 Tau 病理学分期:疾病相关 Tau 病的神经病理学研究标准更新。
Acta Neuropathol. 2024 Oct 14;148(1):53. doi: 10.1007/s00401-024-02805-y.
5
Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration.血液炎症与额颞叶变性中的神经炎症及生存情况相关。
Brain. 2025 Feb 3;148(2):493-505. doi: 10.1093/brain/awae269.
6
CSF Proteomics in Patients With Progressive Supranuclear Palsy.CSF 蛋白质组学在进行性核上性麻痹患者中的应用。
Neurology. 2024 Aug 13;103(3):e209585. doi: 10.1212/WNL.0000000000209585. Epub 2024 Jul 3.
7
Nigrostriatal tau pathology in parkinsonism and Parkinson's disease.黑质纹状体tau 病理学在帕金森病和帕金森综合征中的作用。
Brain. 2024 Feb 1;147(2):444-457. doi: 10.1093/brain/awad388.
8
Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology.伴有tau病理改变的额颞叶痴呆中的胶质细胞反应性和T细胞浸润。
Brain. 2024 Feb 1;147(2):590-606. doi: 10.1093/brain/awad309.
9
Stereology neuron counts correlate with deep learning estimates in the human hippocampal subregions.体视学神经元计数与人类海马亚区深度学习估计相关。
Sci Rep. 2023 Apr 11;13(1):5884. doi: 10.1038/s41598-023-32903-y.
10
The Rossy Progressive Supranuclear Palsy Centre: Creation and Initial Experience.罗西进行性核上性麻痹中心:创建与初步经验。
Can J Neurol Sci. 2023 Nov;50(6):845-852. doi: 10.1017/cjn.2022.332. Epub 2023 Jan 5.